Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Moderna, Inc. Transaction History
Fjarde Ap Fonden (The Fourth Swedish National Pensionfund)
- $8.86 Billion
- Q2 2024
A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Moderna, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 52,430 shares of MRNA stock, worth $1.94 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
52,430Holding current value
$1.94 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
952Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.57 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.49 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$944 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$622 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$267 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...